SBC Medical Group Reports Strong Q2 EBITDA Growth Amid Expansion
SBC Medical Group reported strong financial performance in the second quarter of 2026, with revenue rising 13% year over year to $49 million and adjusted EBITDA surging by 32% to $20 million. The company attributed this growth primarily to increased management services revenue, a revised points business model implemented in June 2025, and higher service fees—despite the weaker yen acting as a headwind. The clinic network expanded significantly during the quarter, growing from 253 locations to 287. Customer visits rose by 10%, with average spending per visit increasing by 9%. SBC is also expanding its presence in aesthetic dermatology and men's hair removal through new formats like THE LASER and SBC MEN'S FLASH. Looking ahead, the company plans further growth initiatives including non-aesthetic healthcare services, AI-powered offerings, international partnerships such as an asset-light model in Thailand, and a $15 million annual increase from service-fee revisions. It also announced plans for a Japan longevity center and online platform by 2027.
